pharma · Ischemic Stroke · Spinal Cord Injury
Neuroscience Trials Australia
Neuroscience Trials Australia is a pharma organization headquartered in CN. Primary therapeutic focus areas include Ischemic Stroke, Spinal Cord Injury, Stroke, Intracerebral Haemorrhage. NovaPharmaNews links 5 clinical
Parkville, AU HQ
14 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Parkville, AU
- Employees
- 14
- Programs
- 5
- Drugs
- 9
- Patents
- 0
Tranexamic Acid
Phase 2 · small molecule · Intracerebral Haemorrhage
Tranexamic Acid for Intracerebral Haemorrhage is a Phase 2 program (small_molecule) at Neuroscience Trials Australia with 1 ClinicalTrials.gov record(s).
Internal code NTA1702
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Neuroscience Trials Australia
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Intracerebral Haemorrhage
- Status
- completed
- Trials
- 1